Tradestie Institutional Equity Comparison Engine
NTLA vs DNTH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DNTH Overall Edge
DNTH Captures Institutional Edge (3โ0 Pillars ยท 5โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Dianthus Therapeutics, Inc. Common Stock (DNTH) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NTLA trades at N/M Forward P/E with -826.0% operating margin (-48.0% YoY revenue) versus DNTH at N/M Forward P/E and -8683.9% operating margin (+205.6% YoY). In options structure, NTLA sits in BREAKDOWN (78th %ile IV; Dealer Gamma Walls on Pro) against DNTH sits in CONSOLIDATION (7th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
NTLA N/M vs DNTH N/M Fwd P/E
Growth & Margin Winner
DNTH
Op Margin -826.0% vs -8683.9% ยท YoY -48.0% vs +205.6%
Momentum & Technical Winner
DNTH
1Y +15.3% vs +149.5% ยท 52W Pos 20% vs 65%
Options & Structure Winner
DNTH
BREAKDOWN (78th %ile IV) vs CONSOLIDATION (7th %ile IV)
NTLA
NASDAQ
Intellia Therapeutics, Inc
In Vitro & In Vivo Diagnostic Substances
$10.00
+3.09% 1D
Market Cap
$1.5B
1M Return
-12.43%
1Y Return
+15.34%
Forward P/E
N/M
Unified AI Score
49.9 / 100
HOLD
Tech 47.0
Fund 55.0
Flow 59.0
Mom 60.0
DNTH
NASDAQ
Dianthus Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$88.58
-3.52% 1D
Market Cap
$5.2B
1M Return
+22.87%
1Y Return
+149.51%
Forward P/E
N/M
Unified AI Score
34.1 / 100
SELL
Tech 8.0
Fund 43.0
Flow 68.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NTLA +15.34%
DNTH +149.51%
Spread: +134.17 pp (DNTH Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | NTLA Revenue | DNTH Revenue | NTLA Op. Margin | DNTH Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $30M | N/A | -298.6% | N/A | NTLA |
| FY2019 | $40M | N/A | -246.8% | N/A | NTLA |
| FY2020 | $60M | N/A | -235.5% | N/A | NTLA |
| FY2021 | $30M | N/A | -810.4% | N/A | NTLA |
| FY2022 | $50M | N/A | -879.0% | N/A | NTLA |
| FY2023 | $40M | $0M | -1420.5% | -1704.7% | NTLA |
| FY2024 | $60M | $10M | -923.1% | -1633.7% | NTLA |
| FY2025 | $70M | $0M | -651.7% | -8739.3% | NTLA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NTLA | DNTH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.5B | $5.2B | Larger Scale | DNTH |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -48.0% | +205.6% | Higher Growth | DNTH |
| Operating Margin (TTM) Profitability | -826.0% | -8683.9% | Higher Margin | NTLA |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -62.6% | -22.6% | Higher ROE | DNTH |
| 52-Week Range Position Momentum | 20% ($8โ$18) | 65% ($34โ$118) | Stronger Trend | DNTH |
| Beta / 30D Volatility Risk Regime | 2.30ฮฒ ยท 87% Vol | 1.03ฮฒ ยท 41% Vol | Lower Realized Risk | DNTH |
| Unified Institutional Score Composite Signal | 49.9 / 100 (HOLD) | 34.1 / 100 (SELL) | Higher Composite | NTLA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NTLA vs DNTH Buy Guide
NTLA
BREAKDOWN
94d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
78th %ile
IV Regime
Elevated (60thโ80th %ile)
DNTH
CONSOLIDATION
149d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
7th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NTLA nor DNTH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.